Skip to main content
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
3.840
-0.050 (-1.29%)
At close: Feb 27, 2026, 4:00 PM EST
3.829
-0.011 (-0.28%)
After-hours: Feb 27, 2026, 7:41 PM EST

Aurora Cannabis Revenue

Aurora Cannabis had revenue of 94.19M CAD in the quarter ending December 31, 2025, with 6.79% growth. This brings the company's revenue in the last twelve months to 373.12M, up 16.54% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.

Revenue (ttm)
373.12M CAD
Revenue Growth
+16.54%
P/S Ratio
0.80
Revenue / Employee
347,733 CAD
Employees
1,073
Market Cap
217.49M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025343.29M73.66M27.32%
Mar 31, 2024269.64M45.83M20.48%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021245.25M-23.45M-8.73%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 788.90M
Organogenesis Holdings 564.17M
Evolus 285.82M
Akebia Therapeutics 236.20M
Organigram Global 204.21M
Lifecore Biomedical 128.87M
Anika Therapeutics 112.82M
Journey Medical 59.40M
Revenue Rankings

ACB News

More News